2007

Heberprot-P®, a drug for the treatment of diabetic foot ulcers begins to be used in Cuba, which will become a leading product of Cuban biotechnology, for the only therapy in the world for effective healing of neuropathic and ischemic diabetic foot ulcers, which reduces the relative risk of lower limb amputation. It is an injectable formulation, designed for an unmet medical need. That year it is patented in several countries.